Limited Competition: Institutional Development Award (IDeA) for Clinical & Translational Research (CTR) (P30 - CT Optional)

The NIH’s Institutional Development Award (IDeA) for Clinical & Translational Research (CTR) is a limited‑competition grant aimed at building biomedical research capacity in historically under‑funded states. Applicants must be lead or partner institutions located in an IDeA‑eligible state and cannot already hold a CTSA or another active IDeA‑CTR award. Two tracks are offered: • CTR‑Development (CTR‑D) – focuses on workforce development and infrastructure enhancement at institutions with limited clinical research capacity. • CTR‑Network (CTR‑N) – supports statewide or multi‑state networks to expand infrastructure, develop the research workforce, and coordinate clinical research activities across IDeA states. Key points for potential applicants: • Only one application per organization. • Lead institutions must already have externally‑funded C&T research. • Partner institutions must be in the same state or multi‑state region as the lead. • Applications are submitted via the NIH eRA Commons by May 30, 2029; anticipated award start July 16, 2027. • Funding is provided as a grant (no cost‑sharing required) with no published ceiling; typical award sizes range from $1‑5 million over up to five years. • Reporting includes annual RPPRs and final close‑out documentation. • Primary contacts are the NIGMS IDeA CTR scientific contact (email above) and the NIGMS financial contact ([email protected]).